Fresh analysis reveals that individuals who come off blockbuster weight-loss injections like semaglutide or tirzepatide may regain shed pounds at a significantly accelerated pace than those who halt traditional diet and exercise plans.
Research printed in a major medical journal shows that while obese individuals frequently drop a large proportion of their total mass while on the medication, the mass comes back at an average rate of nearly a kilo each month once they quit.
"People buying such treatments must be informed of the danger of quick weight regain when the medication concludes," warns expert Dr. Susan Jebb.
That rate of regain suggests a reversion to original weight in about 18 months.
Weighing Treatments
The research, which examined dozens of trials involving thousands of patients, compared the effects of these new drugs with other pills.
Researchers emphasize that people who lose weight through diet and exercise typically experience a slower creep back—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Nutrition scientists suggest the way of the injections explains the accelerated regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which helps regulate hunger.
"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its own natural GLP-1, and could reduce sensitivity to its effects," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication leads to hunger is uncontrolled, making binge eating much more probable."
An Ongoing Condition?
Medical guidelines suggest the injections for people with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
A number of clinicians argue that, due to the likelihood of relapse, the therapy is often long-term.
This perspective is echoed by pharmaceutical companies, who note that the findings "highlight the persistent character of obesity," akin to managing diseases like high blood pressure.
Patient Testimonies
People who have stopped the medication explain a sudden resurgence of cravings.
"It felt as if something flipping and you become starving," said one woman.
This difficulty is compounded if individuals have not established sustainable dietary or behavioural modifications during therapy.
Widespread Use
Figures suggest that millions of people in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Use is higher among women compared to males.
- The 40s and 50s age group shows the greatest level of interest.
- Many access the medications through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful tools for weight loss, they are not a permanent fix and maintained weight loss hinges on integrated lifestyle changes.
